| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 131 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 116 |
| 2 | TACROLIMUS OINTMENT 0.1% | 116 |
| 3 | PREDNISOLONE ORAL SOLUTION | 102 |
| 4 | PREDNISOLONE | 101 |
| 5 | PREDNISOLONE ORAL | 101 |
| 6 | PREDNISONE | 98 |
| 7 | IBUPROFEN | 94 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 89 |
| 9 | RITUXIMAB | 89 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALLOPURINOL SODIUM | 6 | 0.0106 |
| 1 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | 6 | 0.0047 |
| 2 | RALTEGRAVIR | 18 | 0.0034 |
| 3 | PENICILLAMINE | 3 | 0.0032 |
| 4 | HYDROCORTISONE VALERATE | 2 | 0.0032 |
| 5 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 5 | 0.0028 |
| 6 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 9 | 0.0025 |
| 7 | TRANDOLAPRIL TABLETS | 5 | 0.0025 |
| 8 | SULINDAC | 5 | 0.0021 |
| 9 | SARGRAMOSTIM | 3 | 0.0017 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 2 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 3 | Chemokine Receptor Type 4 Interaction [EPC] | 2 | 0.0015 |
| 4 | Glinide [EPC] | 13 | 0.0015 |
| 5 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 13 | 0.0013 |
| 6 | Antiparasitic [EPC] | 6 | 0.0013 |
| 7 | Pediculicide [EPC] | 6 | 0.0013 |
| 8 | Reducing and Complexing Thiol [EPC] | 3 | 0.0012 |
| 9 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |